MedPath

Born In Guangzhou Intervention Study

Not Applicable
Recruiting
Conditions
Child Development
Pregnancy Complications
Pregnancy Outcomes
Interventions
Behavioral: Lifestyle modification
Registration Number
NCT05503849
Lead Sponsor
Guangzhou Women and Children's Medical Center
Brief Summary

The main objective of this study is to test the efficacy of an intervention package (dietary, physical and lifestyle modification) during pregnancy in improving the clinical outcomes of mother-infant dyads.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
1160
Inclusion Criteria
  • Pregnant women attending prenatal care at Guangzhou Women and Children's Medical Center (GWCMC) <20 weeks' gestation
  • Pregnant women plan to deliver at GWCMC
  • Pregnant women intend to reside in Guangzhou for at least 3 years
Exclusion Criteria
  • Multiple pregnancies
  • Existing medical conditions (uncontrolled diabetes, hypertension or thyroid disease; other serious cardiovascular diseases, respiratory or systematic disorders)
  • Use of drugs (aspirin, metformin, low molecular weight heparin)
  • Women with reading and/or writing difficulties
  • Women with serious mental disorders
  • Women with eating disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Proactive management during pregnancyLifestyle modificationA combination of dietary, physical activity and lifestyle modification.
Primary Outcome Measures
NameTimeMethod
Child growth parameters (3 years)At three years of age

Weight measured with digital scales in kg, length measured in standing position in cm, using weight and length to derived body mass index, comparing against age and sex-specific references for Z-score.

Maternal gestational weight changeFrom pregnancy until one month postpartum

Maternal weight prior to pregnancy (or within 8 weeks of pregnancy), at around 20, 26, 32 weeks' gestation, before delivery and one month postpartum will be determined by digital scales, changes in maternal weight during pregnancy will be recorded in kg.

Newborn sizeDay 1 after birth

Weight (kg) will be measured with digital scales and height/length (cm) will be measured in supine with tape, comparing against reference to derived gestational age and sex-specific growth parameter Z-scores. To identify whether the neonates was small/appropriate/large for gestational age.

Neonatal skinfold thickness (at birth)Day 1 after birth

Measured with skinfold caliper, a summation of skinfold thickness at several body sites including triceps, biceps, subscapular, suprailiac and thigh, will be derived in cm.

Child blood lipid profile (3 years)At three years of age

Measured by autoanalyzer, total lipids (total cholesterol, triglycerides, high/low density protein cholesterol) expressed in mmol/L.

Child blood glucose profile (3 years)At three years of age

Measured by autoanalyzer, blood glucose level in mmol/L.

Maternal blood glucose profile postpartum (3 years)Three years after delivery

Measured by autoanalyzer, blood glucose level in mmol/L.

Maternal blood insulin profile postpartum (3 years)Three years after delivery

Measured by commercial ELIZA kit, total and free insulin in pmol/L.

Maternal blood lipid profile postpartum (3 years)Three years after delivery

Measured by autoanalyzer, total lipids (total cholesterol, triglycerides, high/low density protein cholesterol) expressed in mmol/L.

Child blood insulin profile (3 years)At three years of age

Measured by commercial ELIZA kit, total and free insulin in pmol/L.

Incidence of pregnancy complicationsFrom 20 weeks' gestation until one month postpartum

Incidence of physician-diagnosed pregnancy complications, including gestational diabetes mellitus, hypertensive disorders

Secondary Outcome Measures
NameTimeMethod
Child growth parameters (1 year)At one year of age

Weight measured with digital scales in kg, length measured with tape in supine position in cm, using weight and length to derived body mass index, comparing against age and sex-specific references for Z-score.

Child growth parameters (6 years)At six years of age

Weight measured with digital scales in kg, length measured in standing position in cm, using weight and length to derived body mass index, comparing against age and sex-specific references for Z-score.

Maternal blood sugar profile postpartum (6 years)Six years after delivery

Measured by autoanalyzer, blood glucose level in mmol/L.

Child skinfold thickness (6 months)At six months of age

Measured with skinfold caliper, a summation of skinfold thickness at several body sites including triceps, biceps, subscapular, suprailiac and thigh, will be derived in cm.

Child skinfold thickness (3 years)At three years of age

Measured with skinfold caliper, a summation of skinfold thickness at several body sites including triceps, biceps, subscapular, suprailiac and thigh, will be derived in cm.

Child skinfold thickness (6 years)At six years of age

Measured with skinfold caliper, a summation of skinfold thickness at several body sites including triceps, biceps, subscapular, suprailiac and thigh, will be derived in cm.

Child growth parameters (6 months)At six months of age

Weight measured with digital scales in kg, length measured with tape in supine position in cm, using weight and length to derived body mass index, comparing against age and sex-specific references for Z-score.

Child blood sugar profile (6 years)At six years of age

Measured by autoanalyzer, blood glucose level in mmol/L.

Maternal hand grip strength during pregnancyBetween 32-34 weeks' gestation

Measured by high precision digital hand dynamometer, in kg

Maternal hand grip strength after deliveryAt one month postpartum

Measured by high precision digital hand dynamometer, in kg

Maternal blood lipid profile postpartum (6 years)Six years after delivery

Measured by autoanalyzer, total lipids (total cholesterol, triglycerides, high/low density protein cholesterol) expressed in mmol/L.

Child skinfold thickness (1 year)At one year of age

Measured with skinfold caliper, a summation of skinfold thickness at several body sites including triceps, biceps, subscapular, suprailiac and thigh, will be derived in cm.

Child blood lipid profile (6 years)At six years of age

Measured by autoanalyzer, total lipids (total cholesterol, triglycerides, high/low density protein cholesterol) expressed in mmol/L

Child blood insulin profile (6 years)At six years of age

Measured by commercial ELIZA kit, total and free insulin in pmol/L.

Neurological development of child (1 year)At one year of age

Assessed by using Gesell testing, which measures the child's cognitive, language, motor (gross \& fine) and social-emotional responses. Higher score in each domain is desired, there is no upper limit. Overall score of less than 86 indicates suspected developmental retardation.

Neurological development of child (3 years)At three years of age

Assessed by Ages \& Stages Questionnaires, including adaptive, motor (gross \& fine), language, and social function domains, overall score being less than -2SD of age specific mean indicates suspected developmental retardation.

Maternal blood insulin profile postpartum (6 years)Six years after delivery

Measured by commercial ELIZA kit, total and free insulin in pmol/L.

Maternal body composition postpartumAt one month postpartum

Measured by dual-energy X-ray absorptiometry by trained physician, fat mass (kg), fat free mass (kg), and relative proportion (%) and distribution of fat mass will be described.

Trial Locations

Locations (2)

Fuying Campus, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China

🇨🇳

GuangZhou, China

Zhujiang new town campus, Guangzhou Women and Children&#39;s Medical Center, China

🇨🇳

Guangzhou, China

© Copyright 2025. All Rights Reserved by MedPath